Bin Lan

机构：Fujian Medical University, Xiamen University, Chinese PLA General Hospital, First Affiliated Hospital of Fujian Medical University, Fujian Provincial Cancer Hospital · ORCID：0000-0003-3121-7643

发表论文 62 篇 · 总被引 862 次 · h-index 15

代表论文

• Cross Talk Between Ferroptosis and Cerebral Ischemia (2020 · Frontiers in Neuroscience · 被引 79)
• IGF2R-initiated proton rechanneling dictates an anti-inflammatory property in macrophages (2020 · Science Advances · 被引 75)
• Low glucose metabolite 3-phosphoglycerate switches PHGDH from serine synthesis to p53 activation to control cell fate (2023 · Cell Research · 被引 62)
• Role of PRKDC in cancer initiation, progression, and treatment (2021 · Cancer Cell International · 被引 48)
• Electromagnetic navigation bronchoscopic localization versus percutaneous CT ‐guided localization for thoracoscopic resection of small pulmonary nodules (2021 · Thoracic Cancer · 被引 38)
• Gefitinib (an EGFR tyrosine kinase inhibitor) plus anlotinib (an multikinase inhibitor) for untreated, EGFR-mutated, advanced non-small cell lung cancer (FL-ALTER): a multicenter phase III trial (2024 · Signal Transduction and Targeted Therapy · 被引 36)